| 000 | 01616 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516142053.0 | ||
| 264 | 0 | _c20130617 | |
| 008 | 201306s 0 0 eng d | ||
| 022 | _a1472-6874 | ||
| 024 | 7 |
_a10.1186/1472-6874-13-15 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFoster, Shonda A | |
| 245 | 0 | 0 |
_aFractures in women treated with raloxifene or alendronate: a retrospective database analysis. _h[electronic resource] |
| 260 |
_bBMC women's health _cMar 2013 |
||
| 300 |
_a15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlendronate _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast Neoplasms _xepidemiology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xdrug therapy |
| 650 | 0 | 4 |
_aOsteoporotic Fractures _xepidemiology |
| 650 | 0 | 4 |
_aRaloxifene Hydrochloride _xadministration & dosage |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aUnited States _xepidemiology |
| 650 | 0 | 4 | _aWomen's Health |
| 700 | 1 | _aShi, Nianwen | |
| 700 | 1 | _aCurkendall, Suellen | |
| 700 | 1 | _aStock, John | |
| 700 | 1 | _aChu, Bong-Chul | |
| 700 | 1 | _aBurge, Russel | |
| 700 | 1 | _aDiakun, David R | |
| 700 | 1 | _aKrege, John H | |
| 773 | 0 |
_tBMC women's health _gvol. 13 _gp. 15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1472-6874-13-15 _zAvailable from publisher's website |
| 999 |
_c22607767 _d22607767 |
||